Sofgen Pharmaceuticals, part of Procaps Group, is a leading provider of Contract Development and Manufacturing services in Softgel advanced technologies for generic, big pharmaceutical and nutraceutical companies in high regulated markets, will be exhibiting one more year at CPhI North America 2022.
This year at CPhI North America, Sofgen will showcase its innovative softgel technologies featured by Softigel® and a variety of Expertise, Proximity, Integrated development services to help different companies within the US markets to grow and work on challenging projects for their new products.
With unparalleled experience in softgel manufacturing, deep knowledge in formulation and development of complex, niche proprietary products, innovation in oral technologies, Sofgen helps different companies to contribute to the health and well-being of consumers and patients in their key markets.
Join Sofgen by Procaps in CpHi North America from May 17-19, 2022, at the Pennsylvania Convention Center in Philadelphia, PA.
Trust your projects to Sofgen by Procaps Group
Over the years, Sofgen has developed unique products that are recognized for their trusted efficiency, quality, and convenience. In this opportunity, discover a diverse-focused portfolio with top-of-the-market products powered by Softigel’s technologies like Softgels, Unigel TM, Chewgels, Versagel (Plant Based), and G-tabs.
In addition, you will have the chance to learn how our Softgel Technologies have evolved to other innovative formats such as VaoGels (Vaginal Ovules), Twist Gels (Twist Off cap), Enteric Clear SoftGels, and Enteric-Coated SoftGels, Stripe Gels, among others.
Our manufacturing and regulatory expertise have enabled us to become an integrated CDMO (or as we call it, an iCDMO), giving customers full-service, turnkey solutions in prescription and OTC drugs and dietary supplements across both development and delivery. Our Softgel facilities are approved by FDA, MHRA, TGA, and many other regulatory agencies across the globe.
With the acquisition of a new Softgel facility, located in West Palm Beach, Fl, in addition to our high-quality manufacturing capabilities, we are offering access to development and analytical testing capacities, which we believe will become an important alternative for new pharmaceutical and OTC developments in highly regulated markets worldwide. New Softgel encapsulation lines, new critical support systems, automated packaging line capabilities, as well as development facilities including pilot and scale up capabilities, are all part of this new facility.
This acquisition is an important milestone for the company´s strategy of bringing soft gelatin-based innovations to all corners of the globe both via integrated CDMO solutions and our own developments, strategically positioned to improve our supply chain efficiency and the cost of distribution for our products in terms of proximity to customers, especially for the NAFTA area, the largest pharmaceutical market worldwide
Throughout the years, we’ve been continuously working on bringing unique product features to differentiate brands and help you expand goals, with our innovative technologies for healthier lives, as well as our extensive capabilities and deep expertise in product development of Softgels.
Schedule a meeting and visit Sofgen ® during CPhI North America
Make sure you come down and visit us at stand #605 and learn how we can diversify and renovate your portfolio.
To schedule a meeting with us:
Or contact us at:
About Procaps Group:
Procaps Group is a developer of pharmaceutical and nutraceutical solutions, medicines, and hospital supplies that reach more than 50 countries on all five continents and has a direct presence in 13 countries in America with more than 4.500 collaborators working under a sustainable model. Over the years, the company has developed, manufactured, and marketed OTC (over the counter) pharmaceutical products, prescription pharmaceutical drugs (“Rx), nutritional supplements, and high-potency clinical solutions.